| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $31.2M | -22.4% | -30.3% |
| SG&A Expense | $13.7M | -3.8% | -15.9% |
| Operating Income | -$44.9M | +21.0% | +37.4% |
| Net Income | -$41.4M | +18.7% | +37.5% |
| EPS (Basic) | -$0.19 | +17.4% | +40.6% |
| EPS (Diluted) | -$0.19 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.8M | -27.7% | -26.2% |
| Current Assets | $260.7M | -7.8% | -14.4% |
| Total Assets | $439.8M | -6.5% | -25.4% |
| Current Liabilities | $31.8M | +0.5% | -2.3% |
| Total Liabilities | $124.4M | -1.3% | -0.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$121.6M | — | — |
| Capital Expenditures | $386K | — | — |
| Investing Cash Flow | $61.9M | — | — |
| Financing Cash Flow | $22.3M | — | — |
| Free Cash Flow | -$122.0M | — | — |
| +40.6% |
| $315.3M |
| -8.5% |
| -32.0% |